Company news
Nanjing Pharmaceutical Group Company Limited news in 2026
Nanjing Pharmaceutical Group Company Limited's news releases, calls and decks from 2026, newest first.
Announcement on Issuance Result of Phase III Ultra-Short-Term Financing Bonds of 2026
March 9, 2026
Announcement on Progress in Use of Part of the Temporarily Idle Raised Proceeds for Cash Management by the Company and Its Subsidiaries
March 4, 2026
Announcement on Completion of Share Transfer by Shareholders Holding More than 5% of Shares
February 27, 2026
Announcement on the Redemption upon Maturity of Cash Management with Part of Temporarily Idle Raised Funds by the Company and Its Subsidiaries and the Continuation of Cash Management
February 26, 2026
Announcement on Cashing of Phase V Ultra-Short-Term Financing Bonds of 2025
February 10, 2026
Announcement on Canceling Repurchased Shares and Decreasing Registered Capital and Notification to Creditors
February 5, 2026
Indicative Announcement on Convening the 1st Extraordinary General Meeting in 2026
January 28, 2026
Announcement on Unlocking and Listing of Stocks in 3rd Trade Restriction Release Period for the First Granted Part of the 2021 Restricted Stock Incentive Plan
January 26, 2026
Announcement on Cashing of Phase III Ultra-Short-Term Financing Bonds of 2025
January 20, 2026
Announcement on Issuance Result of Phase I Ultra-Short-Term Financing Bonds of 2026
January 19, 2026
Announcement on Redemption of Some Temporarily Idle Raised Funds Used for Cash Management upon Expiration by the Company and Its Subsidiary
January 9, 2026